SKI Market

A+| A| A-|

Indian Indices

Sensex

75,237.99 -160.73
( -0.21%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

61,141.50 -1,512.55
(-2.41%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524558

INE794A01010

1453.5908993

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEULANDLAB

58.55

21260.02

EPS(TTM)

Face Value()

Div & Yield %

283.01

0.21

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1476.84	1558.58	1191.20	951.08	936.91	762.71
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1476.84	1558.58	1191.20	951.08	936.91	762.71
Other Income	96.91	12.54	9.75	2.08	16.09	3.89
Stock Adjustments	-12.83	55.14	9.51	15.41	1.24	11.16
Total Income	1560.92	1626.26	1210.46	968.57	954.24	777.76
EXPENDITURE :
Raw Materials	578.45	636.49	491.98	441.79	443.04	394.41
Power & Fuel Cost	50.56	48.72	48.62	42.21	39.21	32.75
Employee Cost	261.40	248.53	194.84	175.76	144.02	118.48
Other Manufacturing Expenses	108.66	103.73	82.69	84.92	73.71	61.79
Selling & Administrative Expenses	120.52	104.29	88.50	70.50	79.80	51.76
Miscellaneous Expenses	22.11	10.04	22.77	9.12	11.93	13.21
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1141.71	1151.81	929.40	824.29	791.71	672.41
Operating Profit	419.22	474.47	281.06	144.27	162.54	105.34
Interest	8.30	14.00	13.07	13.49	17.90	21.57
Gross Profit	410.92	460.47	267.99	130.78	144.64	83.77
Depreciation	65.54	59.70	52.78	49.04	39.68	31.28
Profit Before Tax	345.38	400.77	215.21	81.74	104.96	52.49
Tax	73.65	99.59	50.39	20.42	12.48	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	12.29	1.59	1.70	-2.22	12.18	36.62
Reported Net Profit	259.43	299.60	163.12	63.53	80.29	15.88
Extraordinary Items	51.90	-0.30	-0.66	-1.36	9.81	0.12
Adjusted Net Profit	207.53	299.90	163.78	64.89	70.48	15.76
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-0.18
P & L Balance brought forward	747.31	460.54	303.84	244.15	166.42	155.67
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	17.96	12.83	6.41	3.85	2.57	4.95
P & L Balance carried down	988.77	747.31	460.54	303.84	244.15	166.42
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	120.00	140.00	100.00	50.00	50.00	20.00
Dividend Per Share(Rs)	12.00	14.00	10.00	5.00	5.00	2.00
Earnings Per Share-Unit Curr	201.10	232.24	126.44	49.25	62.24	12.31
Earnings Per Share(Adj)-Unit Curr	201.10	232.24	126.44	49.25	62.24	12.31
Book Value-Unit Curr	1175.89	988.88	765.49	647.06	605.44	546.26
Book Value(Adj)-Unit Curr	1175.89	988.88	765.49	647.06	605.44	546.26

75,237.99 -160.73 ( -0.21%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

61,141.50 -1,512.55 (-2.41%)

10,172.40 -200.53 (-1.93%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)